Pharmaceutical companies seek to make up any lost revenue after striking deals with Donald Trump to lower costs in US
US pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to withhold new medicine if European lawmakers refuse.
Pfizer chief executive Albert Bourla, the first pharmaceutical boss to annou... [3570 chars]